PCA 50982

Drug Profile

PCA 50982

Latest Information Update: 23 Nov 2006

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Alter
  • Class Anti-ischaemics; Ischaemic heart disorder therapies
  • Mechanism of Action Calcium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Angina pectoris; Myocardial ischaemia

Most Recent Events

  • 01 Sep 1998 No-Development-Reported for Angina pectoris in Spain (Unknown route)
  • 01 Sep 1998 No-Development-Reported for Myocardial ischaemia in Spain (Unknown route)
  • 25 Oct 1995 Preclinical development for Angina pectoris in Spain (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top